Advanced Cancer Therapeutics

About:

Advanced Cancer Therapeutics, LLC engages in the discovery, development, manufacture, and commercialization of cancer therapeutics.

Website: http://www.advancedcancertherapeutics.com

Top Investors: National Cancer Institute, Commonweal Ventures, Commonwealth Seed Capital

Description:

Advanced Cancer Therapeutics, LLC engages in the discovery, development, manufacture, and commercialization of cancer therapeutics. It develops a pipeline of anti-cancer products, including MIF, a macrophage migration inhibitory factor; PU27, a synthetic oligonucleotide that is used as an anticancer compound; PFKFB3, a small molecule compound; CK37, a small molecule that inhibits cell proliferation, choline kinase enzymatic activity, and tumor growth; and a vaccine for human papilloma virus, which is caused for cervical cancer. The company was founded in 2007 and is based in Louisville, Kentucky.

Total Funding Amount:

$10.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Louisville, Kentucky, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)advancedcancertherapeutics.com

Founders:

Tyree Wilburn G.

Number of Employees:

1-10

Last Funding Date:

2012-10-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai